Table 1.
Protein | Method | Lipid | Function | Selected references |
---|---|---|---|---|
β2-adrenergic receptor) | X-ray crystallography | Chol | Protein fold (putative) | Hanson et al. 2008 |
Caveolin-1 | SDS-PAGE, in vitro oligomerization | Chol | oligomeric state | Monier et al. 1995; Murata et al. 1995 |
Cytochrome bc1 complex | X-ray crystallography | PI, CL | Stability and integrity of the complex, enzymatic activity | Gomez and Robinson 1999; Lange et al. 2001 |
Cytochrome c oxidase | X-ray crystallography | PG | Oxygen transfer (putative) | Shinzawa-Itoh et al. 2007 |
K+-channel | X-ray crystallography | anionic PLs | Potassium conductance | Valiyaveetil et al. 2002; Marius et al. 2008 |
Metabotropic glutamate receptor | Agonist binding kinetics, lipid mass spectrometry | Erg | Allosteric effector, targeting to sterol-rich microdomains | Eroglu et al. 2003 |
Mitochondrial ADP/ATP carrier | X-ray crystallography | CL | Oligomeric state | Nury et al. 2005 |
Nitrate reductase A | X-ray crystallography | PG | Oligomeric state/protein fold (“building blocks”) | Bertero et al. 2003 |
Oxytocin receptor | Agonist binding kinetics | Chol | Allosteric effector | Gimpl et al. 2002a |
Peripheral-type benzodiazepine receptor | Ligand-dependent cholesterol uptake and release kinetics, mutational analyses | Chol | Cholesterol transport and compartmentali-zation (putative) | Li and Papadopoulos 1998; Jamin et al. 2005 |
Plasma membrane Ca2+-ATPase | Transport & fluorescence assays | Cer DAG | Allosteric effector | Perez-Gordones et al. 2009 |
Rhodopsin | In vitro photolysis assays, differential scanning calorimetry (DSC) | Chol | Metarhodopsin formation, reprotonation (photocycle) | Mitchell et al. 1990; Bennet et al. 2008 |
Serotonin1a receptor | Agonist binding kinetics | Chol | Allosteric effector | Pucadyil and Chattopadhyay 2004 |
Vacuolar-type Na+-ATPase | X-ray crystallography | DPPG, DPG | Oligomeric state/protein fold (“building blocks”) | Murata et al. 2005 |
For details, see text and Ernst et al. 2010.